arrow
J

Jacek Kubica

Nicolaus Copernicus University
H指数:45
被引数:9,326

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cangrelor in critically ill patients with cardiogenic shock or post-cardiac arrest undergoing percutaneous coronary intervention: a systematic review and meta-analysis

卡格列洛尔在危重患者中的应用:用于心源性休克或心脏骤停后行经皮冠状动脉介入治疗患者的系统评价和荟萃分析

2025-12-280
OAAI
Association Between Lipid-Lowering Therapy and Differences in the Distribution of LDL-C, apoB and non-HDL-C

血脂降低疗法与LDL-C、apoB和non-HDL-C分布差异之间的关系

2025-12-200
OAAI
Prolonged antithrombotic treatment after de-escalation of dual antiplatelet therapy in patients after acute coronary syndrome- which strategy should be applied? The ELECTRA-SIRIO 2 investigators standpoint
2025-02-011
PRE
Treatment of in-stent restenosis with ultrathin-strut versus thin-strut drug-eluting stents or drug-eluting balloons: a multicentre registry
2024-11-010
PRE
Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trial
2024-10-010
PRE
Long-Term Outcomes Following Sirolimus-Coated Balloon or Drug-Eluting Stents for Treatment of In-Stent Restenosis

西罗莫司涂层球囊或药物洗脱支架治疗支架内再狭窄后的长期结果

2024-09-012
PRE
Efficacy and Safety of P2Y 12 monotherapy vs standard DAPT in patients undergoing percutaneous coronary intervention: meta-analysis of randomized trials

P2Y 12单药治疗与标准DAPT在经皮冠状动脉介入治疗患者中的疗效和安全性: 随机试验的荟萃分析

2024-08-012
OAAI
Drug-Eluting Balloons and Drug-Eluting Stents in Diabetic Patients Undergoing Percutaneous Coronary Intervention Due to Restenosis-DM-Dragon Registry
2024-07-300
OAAI